Research conducted at the University of Kiel, Germany, and funded by Novartis AG (SIX: NOVN; NYSE: NVS), suggests that aflibercept, marketed by Regeneron (NASDAQ: REGN)… Read More »Aflibercept may impair wound healing in in vitro cell studies according to Novartis sponsored research
Spark Therapeutics, Inc., (ONCE, NASDAQ), Philadelphia, PA, a retinal gene therapy company, made an impressive IPO debut on the NASDAQ, Friday, January 30th. The company… Read More »Spark Therapeutics makes 117% gain in first day of trading on NASDAQ
Researchers based at the Cantonal Hospital of Lucerne, Switzerland have published research findings suggesting a modest superiority of aflibercept (2 mg) and ranibizumab (0.5 mg)… Read More »Swiss study concludes a modest clinical superiority of aflibercept (2 mg) and ranibizumab (0.5 mg) over other anti-VEGF formulations and dosages
Researchers from the University of Brescia, Italy have published research findings suggesting that smartphones, in combination with an external lens device, can accurately detect retinal… Read More »Comparison of smartphone ophthalmoscopy with slit-lamp biomicroscopy shows potential in grading of diabetic retinopathy
A research team from the Hebrew University of Jerusalem recently demonstrated that the same part of the visual cortex activated in sighted individuals when reading… Read More »Congenitally blind patients reading “through sound” show activation of visual cortex in the brain including response to colour.
GenSight Biologics Inc., Paris, France and Pixium Vision S.A. (Euronext:PIX), Paris, have announced a partnership initiative with the public research organization Fondation Voir et Entendre… Read More »GenSight Biologics announces €18.5M public-private partnership focused on treating retinitis pigmentosa
Results of a subgroup analysis of Japanese wet AMD patients participating in the VIEW2 intravitreal aflibercept study has shown that the treatment is as well… Read More »Japanese subgroup analysis from VIEW2 study of aflibercept (IVT-AFL) indicate consistent results with larger study population
Research results from a systematic review of telemedicine studies, published in the British Journal of Ophthalmology, have shown a high rate of diagnostic accuracy for… Read More »Systematic review and meta-analysis of diabetic retinopathy diagnosis via telemedicine supports its wider use as a powerful tool for screening
In late 2012 research by an international consortium of scientists from Asia showed that three new genes appeared to associate with primary angle closure glaucoma… Read More »GWAS studies highlight three new genes linked to glaucoma, including PLEKHA7, a gene with a putative role in the barrier function of epithelial cells
Amarantus Bioscience Holdings Inc., (AMBS), based in San Francisco, California, has announced that the FDA has granted orphan drug designation for the company’s investigational drug,… Read More »Amarantus receives orphan designation for its anti-apoptotic drug (MANF) for the treatment of retinitis pigmentosa